Sean Mulvany Email & Phone Number

Dublin, County Dublin, Ireland

Investing in Foodtech & AgTech, Biomanufacturing, Bioenergy, Carbon and Nature Based Climate Solutions and other opportunities as part of the Ireland Strategic Investment Fund- Ireland’s sovereign development fund. With a value of €9 billion, the fund has the flexibility to invest across the capital structure, in both debt and equity investments and across a range of investment types and sectors.

Dublin, Ireland

Commercialising lifescience research and intellectual property in DCU through spin outs and licences to companies. Promoting, negotiating and managing company-DCU collaborations.

Dublin

Teagasc is Ireland's national agency responsible for R&D, training and advisory services for the agri-food and AgTech sectors.

I built industry collaborations between companies with a problem statement or innovation requirement and Trinity researchers in ICT and the lifesciences. I also negotiated the licensing of Trinity inventions and technologies to industry.

Dublin

Bringing mHealth and other lifescience opportunities in the university from applied research to commercial implementation.

I took a career break from Enterprise Ireland during which I explored mHealth opportunities arising from university research. I spent much of the period as an Entrepreneur in Residence with VC firm, Delta Partners (http://deltapartners.com).

I worked with Lifescience companies and researchers to develop and commercialise new healthcare technologies and Intellectual Property (IP) across a wide range of therapeutic indications. In parallel, I also helped establish new Lifescience start-ups and promote innovation and access to university-derived IP.

Dublin

ApeRunner is a social media based fundraising platform for charities and non-profits. See http://www.apeworks.com/aperunner and follow us on Twitter @ApeRunner for more details.

Dublin, Ireland

TriMod Therapeutics is a biotechnology start-up focused on the development of a therapeutic cancer vaccine platform technology. See http://www.trimodtherapeutics.com for more information on TriMod.

I was a founder and director of Berand Ltd, a University College Dublin (UCD) spinout. Berand focused in high value collaborative research with large pharma and in house drug development directed against pervasive developmental disorders such as autism (www.berand.ie).

As a senior postdoctoral researcher in an SFI funded collaborative research programme between UCD, TCD and Wyeth, I investigated potential new drug targets to treat schizophrenia and other mental and neurological conditions.

Master'S Degree, Computer Science

Phd, Neuropharmacology